Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

top-wall-street-forecasters-revamp-enerpac-tool-group-expectations-ahead-of-q3-earnings

Top Wall Street Forecasters Revamp Enerpac Tool Group Expectations Ahead Of Q3 Earnings

Jun 26, 2026

Enerpac Tool Group Corp. (NYSE:EPAC) will release earnings for its third quarter after the closing bell on Tuesday,…

Read more
does-truist’s-new-rapp-coverage-subtly-reframe-rapport-therapeutics’-long-term-credibility-story-(rapp)?

Does Truist’s New RAPP Coverage Subtly Reframe Rapport Therapeutics’ Long-Term Credibility Story (RAPP)?

Jun 26, 2026

Earlier this week, Truist Financial’s Danielle Brill initiated coverage of Rapport Therapeutics with a buy rating, citing her…

Read more
qiagen-nv.-updates-earnings-calendar,-shares-tracked-against-diagnostics-peers

Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers

Jun 26, 2026

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 07:11. Qiagen N.V. (NL0012169213) has…

Read more
eni,-friday-focus-on-analyst-views-and-stock-pricing

Eni, Friday focus on analyst views and stock pricing

Jun 26, 2026

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 05:09. Eni S.p.A. (IT0003128367) is…

Read more
micron-stock-jumps-with-analysts-and-the-market-loving-its-earnings

Micron Stock Jumps With Analysts and the Market Loving Its Earnings

Jun 26, 2026

Please enable JS and disable any ad blocker

Read more
1-reason-rapport-therapeutics-(rapp)-looks-pricey-following-truist-buy-coverage

1 Reason Rapport Therapeutics (RAPP) Looks Pricey Following Truist Buy Coverage

Jun 25, 2026

Coverage of Rapport Therapeutics (RAPP) has expanded after Truist Financial analyst Danielle Brill initiated research on the company,…

Read more
longtime-horse-racing-broadcaster-abruptly-leaves-fanduel-tv-coverage-with-another-star-analyst-to-depart

Longtime horse racing broadcaster abruptly leaves FanDuel TV coverage with another star analyst to depart

Jun 25, 2026

Verifying your device, please wait Verification failed. Please try again.

Read more
ars-pharma-reaffirms-2027-breakeven-goal-despite-missing-july-neffy-coverage-wins

ARS Pharma Reaffirms 2027 Breakeven Goal Despite Missing July Neffy Coverage Wins

Jun 25, 2026

The company also lowered its projected 2026 operating expenses, citing tighter cost controls and prioritizing commercial investments. No…

Read more
ingles-markets-earnings-calendar-and-analyst-views,-shares-tracked-on-nasdaq

Ingles Markets earnings calendar and analyst views, shares tracked on Nasdaq

Jun 25, 2026

¼´ŒHNZÐ>çý.­ÿX>§ƒü~f‘ÝM±iG†,˖ž%Ù#Éí^N.P¸ªÐæîŸ„?Úö ™h¢ï¿L}µ³rîJGxP:¤ÖãÖE#½°+íá Í$g ’T$Áÿß¾Ý;@ꋄRˆÁŽ±Ò¸+R¨œ‹ÆU±(íÒ¥»TT£´nú|i›½Ì#¢” *“ÔlÌþÇWú¯”=@VÏÆ`¶Ï60òð£x¯`›*ò»¯ú9=-FÍw pr8ºà6œÓ‘§Ÿñ4″€:Eû¨™RÁ—ší

Read more

Why UK equity research analysts matter more than ever

Jun 25, 2026

At a time when the UK is focused on revitalising its capital markets and attracting new IPOs, one…

Read more
is-upstream-bio,-inc.-(upb)-a-rising-biotech-opportunity-after-new-analyst-coverage?

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

Jun 25, 2026

Laiba Immad Thu, June 25, 2026 at 8:42 AM EDT 2 min read We recently compiled a list…

Read more
is-upstream-bio,-inc.-(upb)-a-rising-biotech-opportunity-after-new-analyst-coverage?

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage?

Jun 25, 2026

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 15
  6. 16
  7. 17
  8. 18
  9. 19
  10. 20
  11. 21
  12. ...
  13. 452
  14. »

Posts pagination

Newer posts Page 1 … Page 18 … Page 452 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.